ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 105 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.20 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $18,506 | -40.6% | 5,591 | -27.5% | 0.00% | – |
| Q1 2024 | $31,136 | -19.1% | 7,707 | -38.9% | 0.00% | – |
| Q4 2023 | $38,485 | -24.2% | 12,618 | -25.4% | 0.00% | – |
| Q3 2023 | $50,745 | -46.8% | 16,915 | -33.7% | 0.00% | – |
| Q2 2023 | $95,370 | -69.7% | 25,500 | -72.9% | 0.00% | – |
| Q1 2023 | $315,228 | -31.4% | 94,098 | -1.5% | 0.00% | -100.0% |
| Q4 2022 | $459,663 | -14.6% | 95,564 | +1.0% | 0.00% | 0.0% |
| Q3 2022 | $538,000 | -22.3% | 94,592 | -3.0% | 0.00% | 0.0% |
| Q2 2022 | $692,000 | +128.4% | 97,524 | +132.3% | 0.00% | – |
| Q1 2022 | $303,000 | -31.0% | 41,985 | -14.5% | 0.00% | -100.0% |
| Q4 2021 | $439,000 | -74.2% | 49,115 | +1.3% | 0.00% | -50.0% |
| Q3 2021 | $1,699,000 | -11.1% | 48,466 | -45.5% | 0.00% | 0.0% |
| Q2 2021 | $1,912,000 | +40.6% | 89,007 | +304.1% | 0.00% | 0.0% |
| Q1 2021 | $1,360,000 | +48.5% | 22,025 | +0.4% | 0.00% | +100.0% |
| Q4 2020 | $916,000 | – | 21,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 5,462,079 | $16,659,341 | 12.62% |
| TANG CAPITAL MANAGEMENT LLC | 4,076,741 | $12,434,060 | 1.15% |
| Stonepine Capital Management, LLC | 839,514 | $2,560,518 | 1.11% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,581,196 | 0.73% |
| CM Management, LLC | 270,000 | $823,500 | 0.66% |
| EcoR1 Capital, LLC | 6,995,861 | $21,337,376 | 0.55% |
| Acuitas Investments, LLC | 171,098 | $615,373 | 0.32% |
| Newtyn Management, LLC | 508,474 | $1,550,846 | 0.30% |
| Diametric Capital, LP | 161,524 | $492,648 | 0.30% |
| Auour Investments LLC | 177,000 | $670,830 | 0.26% |